Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage LivaNova Q1 2026 Earnings EPS Beats Estimates by 71 as Company Highlights Operational Efficiencies EIC Q4 2025 Earnings Narrow EPS Miss Amid Steady Performance CAMP Q1 2026 Earnings WiderThanExpected Loss Pressures Sentiment but Stock Holds Steady INSM Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues GLRE Q1 2026 Earnings Strong Profitability Drives Positive Market Response